image
Bausch + Lomb Corporation BLCO
Healthcare - Medical - Instruments & Supplies - NYSE - CA
Watchlist
$ 16.08
0.5 %
$ 5.67 B
Market Cap
-17.87
P/E
CASH FLOW STATEMENT
232 M OPERATING CASH FLOW
1464.71%
Growth Rates
1Year 1464.71%
3Years -35.71%
5Years -21.91%
7Years 0.00%
10Years 0.00%
-412 M INVESTING CASH FLOW
80.46%
Growth Rates
1Year 80.46%
3Years -24.40%
5Years -17.24%
7Years 0.00%
10Years 0.00%
178 M FINANCING CASH FLOW
-91.43%
Growth Rates
1Year -91.43%
3Years 31.04%
5Years 18.06%
7Years 0.00%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Bausch + Lomb Corporation
image
Net Income -305 M
Depreciation & Amortization 436 M
Capital Expenditures -291 M
Stock-Based Compensation 92 M
Change in Working Capital 0
Others 19 M
Free Cash Flow -59 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
OPERATING CASH FLOW
Net Income (305.0) (248.0) 15.0 193.0 (17.0) 303.0 719.0
Depreciation & Amortization 436.0 382.0 379.0 415.0 442.0 469.0 495.0
Deferred Income Tax (10.0) (10.0) (90.0) 116.0 97.0 (39.0) (444.0)
Stock Based Compensation 92.0 74.0 62.0 62.0 50.0 50.0 43.0
Other Operating Activities 19.0 72.0 (2.0) 59.0 9.0 56.0 28.0
Change in Working Capital 0 (287.0) (19.0) 28.0 (59.0) (40.0) (78.0)
Cash From Operations 232.0 (17.0) 345.0 873.0 522.0 799.0 763.0
INVESTING CASH FLOW
Capital Expenditures (291.0) (181.0) (175.0) (209.0) (259.0) (180.0) (101.0)
Other Items (121.0) (1 928.0) (40.0) (5.0) 3.0 (6.0) 27.0
Cash From Investing Activities (412.0) (2 109.0) (215.0) (214.0) (256.0) (186.0) (74.0)
FINANCING CASH FLOW
Common Stock Repurchased 0 (10.0) 0 0 0 0 0
Total Debt Repaid 201.0 2 115.0 2 458.0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0
Other Financing Activities (23.0) (37.0) (2 377.0) (712.0) (232.0) (606.0) (665.0)
Cash From Financing Activities 178.0 2 078.0 81.0 (712.0) (232.0) (606.0) (665.0)
CHANGE IN CASH
Net Change In Cash (18.0) (46.0) 203.0 (61.0) 46.0 4.0 16.0
FREE CASH FLOW
Free Cash Flow (59.0) (198.0) 170.0 664.0 263.0 619.0 662.0